ARLINGTON, Va.–(BUSINESS WIRE)–Chip Hance assumed the position of Chair of the Board of Directors of the Medical Device Innovation Consortium at the organization’s most recent Board meeting. Hance, a longtime leader in the medical device field, reflected on the opportunities ahead for MDIC as he assumed Board leadership from the outgoing chair, Dr. Jijo James, Chief Medical Officer, MedTech and External Innovation at Johnson and Johnson.
“I am humbled by the opportunity to serve as Chair of the MDIC Board of Directors,” said Hance. “I have been involved with MDIC since its inception and look forward to driving even greater impact of MDIC’s essential work in accelerating medical device innovation and patient access. My priorities as Board Chair include expanding our membership base, especially among small and mid-sized manufacturers, and expanding adoption of MDIC’s programs in the medical technology ecosystem.”
“I am grateful for Jijo’s visionary leadership as chairman to advance MDIC’s mission,” said Andrew Fish, President and CEO of MDIC. “Chip is a passionate champion of the value of medical device innovation to improve and save lives, and I look forward to working with him to continue elevating MDIC’s thought leadership and impact.”
Hance currently serves as CEO, of Regatta Medical, a private equity investment partnership with GTCR. Regatta builds specialty technology companies with unique relevance to the medical device industry. A 35-year industry veteran of cardiovascular, diabetes and diagnostics devices, Hance has long served as the primary MDIC champion of the Early Feasibility Studies program. Previously Hance has served as CEO of Creganna Medical, Entrepreneur-in-Residence at CDRH, and President of Abbott Vascular, the cardiovascular device division of Abbott.
Hance began his two-year term as chair at the 2023 Annual Public Forum. Learn more about MDIC’s leadership.
About the Medical Device Innovation Consortium (MDIC)
At MDIC, we work together to innovate for better health, transforming lives by accelerating access to medical devices. MDIC advances the scientific and technical disciplines that are fundamental to medical technology throughout the total product life cycle. Founded in 2012, MDIC is the premier public-private partnership convening medical device manufacturers, researchers, regulators, payers, patients, and health care providers as trusted collaborators to solve the industry’s complex challenges. Our impact is driving advancements in medical technology development, approval, coverage, adoption, and patient access in the core areas of quality design & manufacturing, evidence generation, digital health, and patient engagement. Learn more about our work at MDIC.org.